LONDON, May 1, 2014 /PRNewswire/ --
On Wednesday, April 30, 2014, the NASDAQ Composite ended at 4,114.56, up 0.27%, the Dow Jones Industrial Average finished the day 0.27% higher at 16,580.84, and the S&P 500 closed at 1,883.95, up 0.30%. The gains were board based as nine out of the ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 672.95, up 0.14%, and the index has advanced 3.87% in the previous three months. Investor-Edge has initiated coverage on the following equities: IsoRay Inc. (NYSE MKT: ISR), Catamaran Corporation (NASDAQ: CTRX), Castlight Health Inc. (NYSE: CSLT) and Sanofi (NYSE: SNY). Free technical research on ISR, CTRX, CSLT and SNY can be downloaded upon signing up at:
http://www.investor-edge.com/2008-register
IsoRay Inc.'s stock surged 29.57%, to close the day at $2.41.The stock recorded a trading volume of 21.62 million shares, much above its three months average volume of 8.33 million shares. The stock oscillated between $2.13 and $2.61 during the session. Over the previous three trading sessions and over the last three months, IsoRay Inc.'s shares have rallied 10.55% and 225.73%, respectively. Additionally, from the beginning of 2014, the company's stock has gained upside of 382.00%. The stock is trading above its 50-day and 200-day moving averages. The company stock's 50-day moving average of $1.82 is above its 200-day moving average of $0.91. Further, the stock has a Relative Strength Index of 39.60. On April 30, 2014, IsoRay Inc. announced that a publication of peer study showed the improved results that, using IsoRay's cesium-131 seeds helps in treating gynecologic cancer. Sign up today to read free research on ISR at:
http://www.investor-edge.com/2008-ISR-01May2014.pdf
Shares in Catamaran Corp.'s finished the Wednesday's session 2.61% lower at $37.75. A total of 5.29 million shares were traded, which was above its three months average volume of 2.58 million shares. The stock moved between $36.98 and $38.99 during the session. Over the previous three trading sessions and last one month, Catamaran Corp.'s shares have declined 3.08% and 15.66%, respectively. Additionally, the stock has plummeted 20.46% since the start of this year. The company's shares are trading below their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $48.55 is greater than its 50-day moving average of $44.36. Catamaran Corp.'s stock has an RSI of 29.32. Sign up today to read free research on CTRX at:
http://www.investor-edge.com/2008-CTRX-01May2014.pdf
On Wednesday, Shares in Castlight Health Inc. fluctuated between $14.48 and $15.57 before ending the session 2.91% lower at $15.02. Castlight Health Inc.'s stock reported a trading volume of 0.63 million shares during the session. Castlight Health Inc.'s shares have advanced 6.83% in the previous three trading sessions. However the stock has declined 29.22% in the last one month. Additionally, shares of the company have an RSI of 46.95. Sign up today to read free research on CSLT at:
http://www.investor-edge.com/2008-CSLT-01May2014.pdf
On Wednesday, Sanofi's stock recorded a trading volume of 1.28 million shares, lower than its three months average volume of 1.63 million shares. The stock finished the day at $53.80, up 0.88%, and registered an intraday range of $53.80 and $54.23. Sanofi's shares have gained 2.91% in the last one month, 10.02% in the previous three months. Additionally, the stock has gained 0.32% since the start of this year. Furthermore, the company's stock is trading above its 50-day and 200-day moving averages of $51.63 and $51.15, respectively. Shares of the company have an RSI of 59.29. Sign up today to read free research on SNY at:
http://www.investor-edge.com/2008-SNY-01May2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investor-Edge
